Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 21, 2025, announces the publication of Haleon Plc's Annual Report and Form 20-F for the fiscal year ended December 31, 2024. Haleon is a global consumer health leader with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS). Key brands include Advil, Sensodyne, Panadol, and Centrum.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notification of the availability of the full Annual Report, which contains the audited financial statements.
Material Changes
No material changes or comparative financial data are disclosed in this specific filing. Investors must refer to the linked Annual Report for year-over-year analysis.
Guidance, Outlook, and Corporate Events
- Annual Report Availability: The 2024 Annual Report is available on the National Storage Mechanism (data.fca.org.uk) and the company website (haleon.com).
- Annual General Meeting (AGM): Scheduled for May 28, 2025. The Notice of AGM will be distributed to shareholders in due course.
- Shareholder Services: Hard copies of the Annual Report can be requested via the Company Secretariat.
Investor Verification Checklist
- Verify the full audited financial statements in the Annual Report hosted on the company website or the National Storage Mechanism.
- Confirm the date and agenda of the Annual General Meeting once the Notice is published.
- Review the "Regulated Information" section of the Annual Report for any unedited disclosures required by the Disclosure Guidance and Transparency Rules.